位置:首页 > 蛋白库 > MMP11_HUMAN
MMP11_HUMAN
ID   MMP11_HUMAN             Reviewed;         488 AA.
AC   P24347; Q5FX24; Q6PEZ6; Q9UC26;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   03-AUG-2022, entry version 205.
DE   RecName: Full=Stromelysin-3;
DE            Short=SL-3;
DE            Short=ST3;
DE            EC=3.4.24.-;
DE   AltName: Full=Matrix metalloproteinase-11;
DE            Short=MMP-11;
DE   Flags: Precursor;
GN   Name=MMP11; Synonyms=STMY3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-38.
RX   PubMed=1701851; DOI=10.1038/348699a0;
RA   Basset P., Bellocq J.-P., Wolf C., Stoll I., Hutin P., Limacher J.-M.,
RA   Podhajcer O.L., Chenard M.P., Rio M.C., Chambon P.;
RT   "A novel metalloproteinase gene specifically expressed in stromal cells of
RT   breast carcinomas.";
RL   Nature 348:699-704(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-38; LYS-44; LEU-61 AND
RP   PRO-86.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-182.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36.
RX   PubMed=7657606; DOI=10.1074/jbc.270.35.20337;
RA   Anglard P., Melot T., Guerin E., Thomas G., Basset P.;
RT   "Structure and promoter characterization of the human stromelysin-3 gene.";
RL   J. Biol. Chem. 270:20337-20344(1995).
RN   [6]
RP   PROTEIN SEQUENCE OF 81-101.
RX   PubMed=7746327; DOI=10.1038/375244a0;
RA   Pei D., Weiss S.J.;
RT   "Furin-dependent intracellular activation of the human stromelysin-3
RT   zymogen.";
RL   Nature 375:244-247(1995).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-166.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: May play an important role in the progression of epithelial
CC       malignancies.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in stromal cells of breast
CC       carcinomas.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif
CC       binds the catalytic zinc ion, thus inhibiting the enzyme. The
CC       dissociation of the cysteine from the zinc ion upon the activation-
CC       peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ST3ID200.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mmp11/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57766; CAA40918.1; -; mRNA.
DR   EMBL; AY899208; AAW65373.1; -; Genomic_DNA.
DR   EMBL; AP000349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC057788; AAH57788.1; -; mRNA.
DR   EMBL; X84664; CAA59150.1; -; Genomic_DNA.
DR   CCDS; CCDS13816.1; -.
DR   PIR; S13423; S13423.
DR   RefSeq; NP_005931.2; NM_005940.4.
DR   AlphaFoldDB; P24347; -.
DR   SMR; P24347; -.
DR   BioGRID; 110463; 1.
DR   STRING; 9606.ENSP00000215743; -.
DR   BindingDB; P24347; -.
DR   ChEMBL; CHEMBL2867; -.
DR   DrugBank; DB00786; Marimastat.
DR   DrugBank; DB04318; NAlpha-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide.
DR   GuidetoPHARMACOLOGY; 1635; -.
DR   MEROPS; M10.007; -.
DR   iPTMnet; P24347; -.
DR   PhosphoSitePlus; P24347; -.
DR   BioMuta; MMP11; -.
DR   DMDM; 317373418; -.
DR   jPOST; P24347; -.
DR   MassIVE; P24347; -.
DR   PaxDb; P24347; -.
DR   PeptideAtlas; P24347; -.
DR   PRIDE; P24347; -.
DR   ProteomicsDB; 54197; -.
DR   Antibodypedia; 3609; 553 antibodies from 36 providers.
DR   DNASU; 4320; -.
DR   Ensembl; ENST00000215743.8; ENSP00000215743.3; ENSG00000099953.10.
DR   Ensembl; ENST00000612388.3; ENSP00000483349.1; ENSG00000275365.3.
DR   GeneID; 4320; -.
DR   KEGG; hsa:4320; -.
DR   MANE-Select; ENST00000215743.8; ENSP00000215743.3; NM_005940.5; NP_005931.2.
DR   UCSC; uc002zxx.4; human.
DR   CTD; 4320; -.
DR   DisGeNET; 4320; -.
DR   GeneCards; MMP11; -.
DR   HGNC; HGNC:7157; MMP11.
DR   HPA; ENSG00000099953; Group enriched (cervix, endometrium, placenta).
DR   MIM; 185261; gene.
DR   neXtProt; NX_P24347; -.
DR   OpenTargets; ENSG00000099953; -.
DR   PharmGKB; PA30869; -.
DR   VEuPathDB; HostDB:ENSG00000099953; -.
DR   eggNOG; KOG1565; Eukaryota.
DR   GeneTree; ENSGT00940000156340; -.
DR   HOGENOM; CLU_015489_8_3_1; -.
DR   InParanoid; P24347; -.
DR   OMA; IYIFSGG; -.
DR   OrthoDB; 1075463at2759; -.
DR   PhylomeDB; P24347; -.
DR   TreeFam; TF315428; -.
DR   BRENDA; 3.4.24.B3; 2681.
DR   PathwayCommons; P24347; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases.
DR   SignaLink; P24347; -.
DR   BioGRID-ORCS; 4320; 13 hits in 1075 CRISPR screens.
DR   ChiTaRS; MMP11; human.
DR   GeneWiki; MMP11; -.
DR   GenomeRNAi; 4320; -.
DR   Pharos; P24347; Tchem.
DR   PRO; PR:P24347; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P24347; protein.
DR   Bgee; ENSG00000099953; Expressed in stromal cell of endometrium and 98 other tissues.
DR   ExpressionAtlas; P24347; baseline and differential.
DR   Genevisible; P24347; HS.
DR   GO; GO:0031012; C:extracellular matrix; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071711; P:basement membrane organization; IEA:Ensembl.
DR   GO; GO:0030574; P:collagen catabolic process; IBA:GO_Central.
DR   GO; GO:0030199; P:collagen fibril organization; IEA:Ensembl.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   CDD; cd00094; HX; 1.
DR   CDD; cd04278; ZnMc_MMP; 1.
DR   Gene3D; 2.110.10.10; -; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR000585; Hemopexin-like_dom.
DR   InterPro; IPR036375; Hemopexin-like_dom_sf.
DR   InterPro; IPR018487; Hemopexin-like_repeat.
DR   InterPro; IPR018486; Hemopexin_CS.
DR   InterPro; IPR033739; M10A_MMP.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001818; Pept_M10_metallopeptidase.
DR   InterPro; IPR021190; Pept_M10A.
DR   InterPro; IPR021158; Pept_M10A_Zn_BS.
DR   InterPro; IPR006026; Peptidase_Metallo.
DR   InterPro; IPR028705; Stromelysin-3.
DR   PANTHER; PTHR10201:SF20; PTHR10201:SF20; 1.
DR   Pfam; PF00045; Hemopexin; 4.
DR   Pfam; PF00413; Peptidase_M10; 1.
DR   PIRSF; PIRSF001191; Peptidase_M10A_matrix; 1.
DR   PRINTS; PR00138; MATRIXIN.
DR   SMART; SM00120; HX; 4.
DR   SMART; SM00235; ZnMc; 1.
DR   SUPFAM; SSF50923; SSF50923; 1.
DR   PROSITE; PS00546; CYSTEINE_SWITCH; 1.
DR   PROSITE; PS00024; HEMOPEXIN; 1.
DR   PROSITE; PS51642; HEMOPEXIN_2; 4.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cleavage on pair of basic residues; Collagen degradation;
KW   Direct protein sequencing; Disulfide bond; Extracellular matrix; Hydrolase;
KW   Metal-binding; Metalloprotease; Protease; Reference proteome; Repeat;
KW   Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   PROPEP          32..97
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000028770"
FT   CHAIN           98..488
FT                   /note="Stromelysin-3"
FT                   /id="PRO_0000028771"
FT   REPEAT          291..339
FT                   /note="Hemopexin 1"
FT   REPEAT          340..382
FT                   /note="Hemopexin 2"
FT   REPEAT          384..432
FT                   /note="Hemopexin 3"
FT   REPEAT          433..480
FT                   /note="Hemopexin 4"
FT   REGION          41..93
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           78..85
FT                   /note="Cysteine switch"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        216
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         80
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250"
FT   BINDING         166
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         171
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         172
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         174
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         176
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         179
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         192
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         215
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         219
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         225
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   DISULFID        294..480
FT                   /evidence="ECO:0000250"
FT   VARIANT         38
FT                   /note="A -> V (in dbSNP:rs738792)"
FT                   /evidence="ECO:0000269|PubMed:1701851, ECO:0000269|Ref.2"
FT                   /id="VAR_022181"
FT   VARIANT         44
FT                   /note="E -> K (in dbSNP:rs28363646)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_022182"
FT   VARIANT         61
FT                   /note="P -> L (in dbSNP:rs28363647)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_022183"
FT   VARIANT         86
FT                   /note="S -> P (in dbSNP:rs28363648)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_022184"
FT   VARIANT         166
FT                   /note="D -> N (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036140"
FT   VARIANT         182
FT                   /note="F -> S (in dbSNP:rs17854940)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_029659"
SQ   SEQUENCE   488 AA;  54590 MW;  F03C537EE76706A9 CRC64;
     MAPAAWLRSA AARALLPPML LLLLQPPPLL ARALPPDAHH LHAERRGPQP WHAALPSSPA
     PAPATQEAPR PASSLRPPRC GVPDPSDGLS ARNRQKRFVL SGGRWEKTDL TYRILRFPWQ
     LVQEQVRQTM AEALKVWSDV TPLTFTEVHE GRADIMIDFA RYWHGDDLPF DGPGGILAHA
     FFPKTHREGD VHFDYDETWT IGDDQGTDLL QVAAHEFGHV LGLQHTTAAK ALMSAFYTFR
     YPLSLSPDDC RGVQHLYGQP WPTVTSRTPA LGPQAGIDTN EIAPLEPDAP PDACEASFDA
     VSTIRGELFF FKAGFVWRLR GGQLQPGYPA LASRHWQGLP SPVDAAFEDA QGHIWFFQGA
     QYWVYDGEKP VLGPAPLTEL GLVRFPVHAA LVWGPEKNKI YFFRGRDYWR FHPSTRRVDS
     PVPRRATDWR GVPSEIDAAF QDADGYAYFL RGRLYWKFDP VKVKALEGFP RLVGPDFFGC
     AEPANTFL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024